Dr. Afrand Kamali Sarvestani has an interest in biochemicals and their corresponding biological pathways. He graduated with his PhD from Michigan State University. He has several years of experience in the pharmaceutical and biotechnology industries. He is currently a senior scientist at Novo Nordisk.